Failure to maintain general records.
Inspection Record
Innovative Transfusion Medicine, Inc. — FDA 483 Findings
Inspectors Sergio E Delgado · Nerming V BrionesThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Failure to review all records required under the regulations to identify previously donated blood and blood components within 3 calendar days after a donor tests reactive for evidence of HIV infection indicating evidence of HIV infection.
Written standard operating procedures including all steps to be followed in the collection, processing and storage of blood and blood components for further manufacturing purposes were not always followed.
Failure to review all records required under the regulations to identify previously donated blood and blood components within 3 calendar days after a donor tests reactive for evidence ofHCV infection indicating evidence of HCV infection.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.